FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Aveva Drug Delivery Systems, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for the Nicotine Transdermal System by Aveva Drug Delivery Systems, Inc. (ANDA074612).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Nicotine Transdermal System (Nicotine)

Snippet

SUPPL AP for NICOTINE TRANSDERMAL SYSTEM (NICOTINE TRANSDERMAL SYSTEM)